Explorative study of emerging blood biomarkers in progressive multiple sclerosis (EmBioProMS): Design of a prospective observational multicentre pilot study

BACKGROUND: Defining clinical and subclinical progression in multiple sclerosis (MS) is challenging. Patient history, expanded disability status scale (EDSS), and magnetic resonance imaging (MRI) all have shortcomings and may underestimate disease dynamics. Emerging serum biomarkers such as glial fi...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdelhak, Ahmed, Huss, Andre, Stahmann, Alexander, Senel, Makbule, Krumbholz, Markus, Kowarik, Markus C., Havla, Joachim, Kümpfel, Tania, Kleiter, Ingo, Wüstinger, Isabella, Zettl, Uwe K., Schwartz, Margit, Roesler, Romy, Friede, Tim, Ludolph, Albert C., Ziemann, Ulf, Tumani, Hayrettin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7251538/
https://www.ncbi.nlm.nih.gov/pubmed/32478196
http://dx.doi.org/10.1016/j.conctc.2020.100574

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7251538/
https://www.ncbi.nlm.nih.gov/pubmed/32478196
http://dx.doi.org/10.1016/j.conctc.2020.100574

Ejemplares similares